Marinus Pharmaceuticals
MRNS
#10035
Rank
โ‚น2.72 B
Marketcap
โ‚น49.41
Share price
0.00%
Change (1 day)
-60.04%
Change (1 year)

Revenue for Marinus Pharmaceuticals (MRNS)

Revenue in 2024 (TTM): โ‚น2.62 Billion

According to Marinus Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น2.82 Billion. In 2023 the company made a revenue of โ‚น2.57 Billion an increase over the revenue in the year 2022 that were of โ‚น2.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Marinus Pharmaceuticals from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น2.62 B1.8%
2023 โ‚น2.57 B22.36%
2022 โ‚น2.10 B84.59%
2021 โ‚น1.14 B809.03%
2020 โ‚น0.12 B
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AcelRx Pharmaceuticals
ACRX
โ‚น58.48 M-97.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
โ‚น23.13 B 718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
โ‚น180.70 B 6,292.67%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Supernus Pharmaceuticals
SUPN
โ‚น61.22 B 2,065.95%๐Ÿ‡บ๐Ÿ‡ธ USA